Pharmaceuticals articles
-
TRACON Pharmaceuticals (NASDAQ:TCON) Shares Scheduled to Reverse Split on Wednesday, April 10th
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report)’s stock is scheduled to reverse split on Wednesday, April 10th. The 1-20 reverse split was announced on Wednesday, April 10th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, April 10th. TRACON Pharmaceuticals Trading Down 24.8 % TCON traded down $0.06 […]
-
Stephen Davis Sells 26,574 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stock
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 26,574 shares of the stock in a transaction on Monday, April 8th. The stock was sold at an average price of $17.87, for a total transaction of $474,877.38. Following the sale, the chief executive officer now directly owns 144,267 shares in the company, […]
-
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disord